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Abstract
Background: The aim of our study was to examine the value of Holter monitoring and
changes of heart rate variability (HRV) parameters in patients undergoing percutaneous
transluminal coronary angioplasty (PTCA) and to assess their value for detection of restenosis
after the elective PTCA of single-vessel coronary artery disease.
Methods: 56 consecutive patients were studied — 41 men and 15 women (mean age: 56.2 ± 8.3 years)
with left anterior descending artery stenosis who underwent successful PTCA. All patients
underwent 24 hour Holter monitoring with HRV assessment within 1 week after PTCA and
then again before repeated follow-up angiography.
Results: Repeated coronary angiography revealed restenosis in 15 patients and no signs of
significant stenosis in the remaining 41 patients. The sensitivity of standard ST-segment
depression criteria for the prediction of restenosis was low (ranging from 7% to 27%), with
quite high specificity (80–93%) and very low diagnostic accuracy (17–36%). However, the
presence of ventricular extrasystoles (≥ 50 during 24 h registration) was statistically signifi-
cantly associated with quite a high likelihood of the presence of restenosis — sensitivity
(53% and 47%), specificity (76% and 85%) and diagnostic accuracy (44% and 54%), respec-
tively. In baseline recordings the significantly higher values of rMSSD (p < 0.05) and pNN50
(p = 0.61) had been found among patients who later developed restenosis, compared to those
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that did not. The sensitivity of rMSSD ≥ 30 ms for the prediction of restenosis was 60%,
specificity 76%, diagnostic accuracy 47%. Also the sensitivity of pNN50 ≥ 8% for prediction of
restenosis was high and equalled 60%, specificity 78% and diagnostic accuracy 50%.
Conclusions: The value of a 24 hour Holter ST-segment monitoring in the prediction of
restenosis seems to be limited. The possible correlation between frequent ventricular extrasystoles
and the presence of restenosis needs further studies. The value of heart rate variability in the
prediction of restenosis remains to be defined. (Folia Cardiol. 2006; 13: 404–413)
Key words: percutaneous transluminal coronary angioplasty, restenosis, Holter
monitoring, heart rate variability
Introduction
Despite the significant progress that has been
made in recent years in the percutaneous revascula-
rization of the heart muscle — mainly attributable to
the fact of empowering the balloon angioplasty tech-
nique (PTCA) with the implantation of coronary stents
(especially drug-eluting ones) and to the use of va-
ried pharmacotherapy — the phenomenon of reste-
nosis still remains the main problem for an invasive
cardiologist to be faced with. As it has been shown in
previous studies, restenosis occurs in 15–50% of pa-
tients following the procedure of coronary angiopla-
sty and the implantation of a coronary stent seems to
decrease the risk of restenosis — depending on the
type of lesion — only up to a dozen or so percent.
There is a considerable difference between the
percentage of clinically symptomatic restenosis and
the angiographically proven significant stenosis
within the dilated vessel, which may suggest the
need to perform a check-up angiography in all pa-
tients undergoing angioplasty procedures. Never-
theless, such approach has been introduced to some
clinics of cardiology in the world. It is very expen-
sive, carries a certain risk of adverse effects of in-
vasive procedures, and — as it seems — lacks suf-
ficient evidence to prove its advisability. Alternati-
ve strategy includes an attempt to determine, with
the use of noninvasive examination, the group of
patients treated with angioplasty procedures that
are suspected to have developed restenosis and to
perform check-up angiography only in those selec-
ted patients. The true value of noninvasive exami-
nation techniques (that is their sensitivity and spe-
cificity) used to determine the group of patients
with restenosis, still remains an open question.
Standard electrocardiographic exercise test on
a treadmill is a noninvasive method that is most
often used to evaluate patients after coronary an-
gioplasty procedures. But owing to its relatively low
sensitivity and specificity in identifying patients
with restenosis, other methods to evaluate those
patients are continuously searched for.
One of the methods to be used in search of re-
stenosis in patients after angioplasty procedures is
Holter ECG monitoring. The evaluation of the
ST-segment in Holter ECG monitoring as a mar-
ker of cardiac ischemia has a diagnostic and progno-
stic power. Episodes of significant ST-segment al-
terations are considered to reflect ischemia in pa-
tients with a history of coronary artery disease and
are often attributed with a prognostic power.
Relatively few trials explore the importance of
ECG Holter monitoring in patients after coronary
angioplasty procedures, though the advantages of
ambulatory monitoring of ST-segment seem to be
undeniable, especially in the evaluation of sponta-
neous anginal episodes that occur during specific
types of exercise, which cannot be reproduced in
clinical conditions, or during a specific time of a day.
ECG Holter monitoring allows to observe si-
lent ischemia episodes or ischemia-induced arrhy-
thmias that are frequently the first manifestation of
restenosis after angioplasty procedures.
Another method that may be used to estimate
restenosis in patents after angioplasty procedures
is the assessment of heart rate variability (HRV).
This name is used to address momentary fluctu-
ations of the duration of consecutive RR intervals
of the sinus rhythm, that are registered by means
of Holter ECG monitoring. Sinus rhythm variabili-
ty is controlled by the autonomous nervous system,
its sympathetic and parasympathetic part. The
activity of both parts is subject to continuous chan-
ges. The activity of the sympathetic system (vagus
nerve) prevails at rest and under these circumstan-
ces it contributes mostly to heart rate variability
— the influence of activation is fast and it lasts for
a relatively short period of time. Adrenergic stimu-
lation, on the other hand, rises slowly and it is limi-
ted by the activity of the vagus nerve, simultane-
ously modulating its activity [1, 2].
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As it has been shown in many reports, redu-
ced sinus rhythm variability is an independent risk
factor in patients suffering from acute myocardial
infarction. The most proven indicator in this case is the
SDNN parameter, the value of which lower than
50 ms is an indicator of the unfavorable prognosis [2–4].
Despite few reports concerning the use of
Holter ECG monitoring with heart rate variability
assessment in patients after angioplasty procedu-
res that are suspected to develop restenosis, pato-
physiologic and pathogenetic factors seem to sup-
port its use for that purpose, and therefore the at-
tempt to use it to assess the incidence of restenosis
seems to be justified.
The aim of the study was to estimate the abili-
ty of ECG Holter monitoring with heart rate varia-
bility assessment to identify patients with resteno-
sis after the successful coronary angioplasty pro-
cedure.
Methods
The study included patients with symptomatic
coronary artery disease, in which the presence of
significant, isolated stenosis (> 50% of lumen dia-
meter of the artery) of the left anterior descending
artery (de novo lesion), eligible for balloon angio-
plasty, was found during angiographic examination.
Exclusion criteria of the study included:
— presence of hemodynamically significant le-
sions (stenosis of >50% of lumen diameter) in
other coronary arteries, except for diagonal
branches;
— complete occlusion of the left anterior descen-
ding artery (LAD);
— past myocardial infarction with impaired left
ventricular ejection fraction (below 40%);
— chronic atrial fibrillation;
— use of digitalis preparations or medications that
prolong the QT interval;
— lack of patient’s consent to be included in the
study and to undergo control coronarography.
During the enrollment period of the study
(15 October 2000 – 31 July 2001), 814 angioplasty
procedures, including 390 procedures within the left
anterior descending artery, were performed at He-
modynamic Laboratory of the Chair and 1st Depart-
ment of Cardiology, Poznań University of Medical
Sciences. Most of them (n = 315) were procedures
performed in patients with atherosclerotic lesions
also present in other arteries. During that period
there were 75 angioplasty procedures performed in
patients with isolated lesion within LAD. The stu-
dy group consisted of 56 consecutive patients,
fulfilling the inclusion criteria of the study — those
patients were included in the successive analysis.
The remaining 19 patients were not included in the
study for the following reasons: lack of consent to
participate in the study (7 patients), lack of consent
to undergo control coronarography (3 patients), past
myocardial infarction with significant impairment of
left ventricular ejection fraction (5 patients), chro-
nic atrial fibrillation (2 patients), treatment with di-
gitalis preparations or other medications that pro-
long the QT interval (4 patients — including 2 with
atrial fibrillation).
In the study group of 56 patients there were
41 men and 15 women, mean age 56.2 ± 8.3 years
(min. 38, max. 73 years). The time period from the
onset of symptoms to the angioplasty procedure was
considerably diversified, from 1 up to 120 months
and its mean length equaled 16.5 ± 26.2 months.
Among the patients of the study group, 29 pa-
tients (52%) had previously undergone myocardial
infarction — in most cases (n = 18) it was a non-Q
infarction of the anterior wall of the heart. During
medical history data collection 29 patients (52%)
reported arterial hypertension, 8 patients (14%)
— type 2 diabetes (treated with oral medications
in 5 patients, with insulin in 3 patients).
The study described above is a part of a bro-
ader programme, in which the importance of vario-
us noninvasive examinations, used to evaluate the
incidence of restenosis in patients after angiopla-
sty procedures, was assessed. Those examinations
included a standard electrocardiographic exercise
test on a treadmill (Bruce’s method), ECG with the
evaluation of the QT-dispersion at rest and during
exercise, 24-hour ECG Holter monitoring with the
assessment of heart rate variability and signal ave-
raged electrocardiogram with the registration of late
ventricular potentials. The part of the programme
concerning the importance of ECG Holter monito-
ring with the assessment of heart rate variability is
presented in the current paper.
Following the procedure of coronary angiogra-
phy and coronary angioplasty of an isolated lesion
within the left anterior descending artery, inclusion
criteria into the programme were taken into consi-
deration, as well as possible exclusion criteria. The
patient was then informed in detail about the aim,
advantages and possible risk related to the partici-
pation in the study. The patient had an opportunity
to receive the exhaustive explanation of possible qu-
estions or doubts and gave their consent to partici-
pate in the study in writing, having got acquainted
with an “Information for the patient” about the prin-
ciples regarding the participation in the programme.
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During in-hospital stay related to coronary an-
giography and concurrent angioplasty procedure,
the angiographic assessment of the localization of
the lesion being subject to angioplasty was perfor-
med before and after the procedure, adverse effects
of the procedure were estimated, and echocardio-
graphic examination was performed, including the
evaluation of left ventricular ejection fraction.
In addition to that, during the in-hospital stay
related to the procedure (or within 7 days from the
procedure) each patient underwent among other
examinations a 24-h Holter ECG monitoring with
assessment of heart rate variability (according to
the methodology described below).
During in-hospital stay after 6 months form the
angioplasty procedure:
— each patient underwent 24 h Holter ECG regi-
stration with the assessment of HRV;
— control coronary angiography was performed in
each patient with possible concurrent angiopla-
sty in case of angiographically confirmed reste-
nosis (stenosis of > 50% of the diameter of the
artery within the previously dilated segment).
The study protocol described above was accep-
ted by the Local Committee for Ethics in Scientific
Studies at the Medical University of Poznan.
Coronary angiography and angioplasty were
performed according to generally accepted rules,
based on the Guidelines of ACC/AHA and Polish
Cardiac Society (PCS). During angioplasty proce-
dure a stent was successfully implanted in each pa-
tient. The lesion found was estimated before and
after PTCA procedure with the use of QCA system:
the reference diameter of the artery (RD), the mi-
nimal lumen diameter of the artery (MLD), the per-
centage of stenosis of lumen diameter and the
length of stenotic lesion were evaluated. Primary
and restenotic lesions were regarded as significant
if the stenosis observed was greater than 50% of
lumen diameter.
24 hour Holter ECG monitoring with the as-
sessment of HRV — Holter monitoring was perfor-
med in all patients following the angioplasty proce-
dure and after 6 months, before control coronary
angiography, according to the guidelines of PCS [1].
ECG recording was performed for a minimum of
18 hours with the use of three-channel tape recor-
der DRG RT300 with 7 electrodes. Data reading
was performed with the use of a Personal Compu-
ter set and each result was then verified by a car-
diology specialist. The occurrence of silent ische-
mia, arrhythmic profile and HRV were assessed.
Ischemia was defined as the presence of an episo-
de of significant ST-segment lowering of 1 mm
(at 60 ms distance from the J-point), of inclined or
horizontal course, maintaining for at least 1 minute.
For the assessment of arrhythmic profile the
total daily number of ventricular extrasystoles,
number of pairs and number of extrasystoles per
1000 sinus evolutions were taken into account.
For the assessment of sinus rhythm variabili-
ty, according to guidelines of PCS, ESC and
NASPE [1], the following sinus rhythm variability
indexes were calculated:
— SDNN — standard deviation of all RR intervals
of sinus rhythm;
— SDNNI — index of standard deviation of all RR
intervals of sinus rhythm;
— SDANN — standard deviation of the average
of consecutive 5-minute series of RR intervals
of the whole recording;
— rMSSD — square root of mean sum of squared
differences between consecutive RR intervals;
— pNN50 — percentage of differences between
consecutive intervals exceeding 50 ms.
Statistical analysis
An initial phase of statistical analysis — explo-
rative data analysis — included the inspection of
data completeness, reasonableness, the fulfillment
of logical criteria for certain ranges, as well as ba-
sic properties of empirical distributions of attribu-
tes with the identification of atypical results
(outliers). The assessment of conformity of the di-
stributions of investigated attributes with normal
distribution was performed with the use of Shapi-
ro-Wilk test. In cases of discordance of investiga-
ted attributes with normal distribution, median va-
lue and mean deviation as a measure of dispersion
were used. Mann-Whitney test was used for the
analysis of the significance of differences between
median values.
The remaining attributes, having a distribution
significantly different compared to normal distribu-
tion, for which in most cases no positive values were
recorded, were treated as categorial attributes and
for their analysis a precise Fisher test (2 × 2 table)
or chi-square test according to Pearson’s method
and maximum likelihood method (tables 2 × 3 and
larger) were used.
The attributes, the distribution of which did not
significantly differ from normal distribution, were
demonstrated by means of arithmetic average ±
± standard deviation (SD) and the intergroup com-
parison was performed with the use of a t-Student
test for non-linked attributes.
The indexes of diagnostic efficacy (sensitivity,
specificity, the predictive value of positive and
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negative result, odds ratio with 95% confidence
interval) were calculated with the use of standard
equations for contingency table 2 × 2.
Results
Evaluation of the incidence of restenosis
Control coronary angiography after 6 months
from the angioplasty procedure was performed in
all patients. Significant (> 50%) restenosis in LAD
was found in 15 patients (26.8%). All of those pa-
tients had previously undergone angioplasty of LAD
with stent implantation. In-stent restenosis was
diagnosed in 11 patients (20%) and restenosis pro-
ximal to the stent implantation site in 4 patients
(6.8%). Among 11 patients with in-stent resteno-
sis  implantation site: in 3 patients (5.5%) total occ-
lusion of the artery was observed, in next 3 patients
(5.5%) — diffuse restenosis within the stent and
spreading beyond its limits, and in the remaining
5 patients (9.0%) — focal restenosis that did not
spread beyond the limits of the stent.
Excluding the patients with total occlusion of
the artery, the percentage of stenosis of the artery
lumen diameter, calculated with use of QCA in the
remaining 12 patients equaled 67±7% on average.
In 4 patients restenotic lesion was described as si-
gnificant (50–70% of lumen diameter of the artery
— minimal 58%) and in the remaining 8 as critical
(> 70% of lumen diameter of the artery).
In 7 patients after QCA calculations, the lesion
within LAD was regarded as borderline (stenosis
of 40–50% of lumen diameter of the artery). Bor-
derline characteristics of the lesion was indepen-
dently confirmed by three experienced cardiologi-
sts — in case of discrepancy of their opinion, the
patient was qualified to undergo another coronary
angiography with functional assessment of lesion si-
gnificance with the use of the fractional flow rese-
rve evaluation method (FFR). Dubiety concerning
the type of lesion arouse in case of 4 patients that
had undergone FFR evaluation within LAD confir-
ming hemodynamically insignificant characteristics
of the lesion (FFR values > 0.75 in each patient;
min. 0.78, max. 0.91). All of those 7 patients were
finally included into the group without restenosis.
The remaining 34 patients (60.7%), in which
coronary angiography with QCA calculation had not
demonstrated restenosis of the artery greater than
40%, were included into the group without restenosis.
For the successive consideration it was assu-
med that in the study group restenosis occurred in
15 patients (26.8%) and no restenosis was demon-
strated in 41 patients (73.2%).
The group with restenosis was not different
compared to the group without restenosis as re-
gards sex, age, period of angina occurrence before
the angioplasty procedure, the incidence of angina
at rest, CCS class, past myocardial infarction, arte-
rial hypertension, diabetes or nicotinism. Also the
end-diastolic diameter and left ventricular ejection
fraction were comparable in both groups. Detailed
clinical characteristics of both study groups is
shown in Table 1.
Assessment of Holter ECG monitoring for
identification of patients with restenosis
Holter ECG registration was performed in all
patients after angioplasty procedure and after
6 months, before control coronary angiography. The
incidence of silent ischemia, arrhythmic profile and
HRV were assessed.
In the first examination the two groups of pa-
tients — with and without restenosis — were not
Table 1. Clinical and echocardiographic characteristics of patients in the group with and without restenosis.
Restenosis (n = 15) No restenosis (n = 41) p
Men/women 12/3 29/12 NS
Age (years) 58.9 ± 9.3 55.2 ± 7.8 NS
Period of anginal symptoms 8 5 NS
before PTCA (median; months)
Anginal symptoms at rest 8 (53%) 23 (56%) NS
CCS class (mean) 2.8 ± 0.7 2.8 ± 0.7 NS
Past myocardial infarction 7 (47%) 22 (54%) NS
Arterial hypertension 7 (47%) 22 (54%) NS
Diabetes 0 (0%) 8 (20%) NS
Nicotinism 7 (47%) 17 (41%) NS
Diastolic diameter of left ventricular [mm] 48.3 ± 4.4 49.7 ± 6.4 NS
Left ventricular ejection fraction 54.5 ± 7.9 56.2 ± 7.1 NS
PTCA — percutaneous transluminal coronary angioplasty
409
Marek Grygier et al., Holter rate variability after PTCA
www.foliacardiologica.eu
different from each other as regards mean, mini-
mum and maximum heart rate.
Arrhythmic profile in the two examinations was
also assessed. The total number of ventricular
extrasystoles a day and the number of extrasysto-
les per 1000 of sinus rhythm evolutions were ta-
ken into account.
In the first examination, ventricular extrasysto-
les (VES) were present in 39 patients (min. 1;
max. 10.025 extrasystoles) and no VES were found
in 17 patients. In 9 patients the burden of VES was
greater than 1:1000 (min. 1:1000, max. 120:1000).
It has been observed that VES in number greater
than 50 a day were present more often in the group
of patients with restenosis. Among 18 patients with
such number of VES, restenosis occurred in
8 (44%), while among 38 patients with total num-
ber of VES a day lower than 50, restenosis occur-
red only in 7 patients (18%) — the difference obse-
rved was statistically significant (p < 0.05).
In the first ECG recording, the episodes of ische-
mia were observed cumulatively in 13 patients (20%).
In 9 patients the episodes consisted of ST-segment
lowering of 1.0–2.0 mm, in 2 patients > 2.0 mm and
in the remaining 2 — both 1.0–2.0 and > 2.0 mm. It
was determined if the ischemic episodes found in
Holter monitoring immediately after the procedure
allow to predict the occurrence of restenosis. Results
of the analysis described above are shown in Table 2.
In the second Holter ECG recording, performed
before control coronary angiography, ventricular
extrasystoles were present in 37 patients (min. 1;
max. 14,114) and no VES were observed in 18 pa-
tients (in one patient [MS; no. 23] Holter ECG re-
gistration could not be assessed for technical re-
asons). It has been observed that the number of
VES greater than 50/24 h was recorded more often
in the group of patients that developed restenosis.
Among 13 patients with such number of VES, re-
stenosis occurred in 7 patients (54%), while among
42 patients with daily number of VES lower than
50 restenosis developed only in 8 patients (19%)
— the difference observed was statistically significant
(p < 0.05). In 8 patients VES burden was greater than
1:1000 (min. 1:1000, max. 153:1000) — in that group
restenosis was diagnosed in 5 patients and no reste-
nosis was found in 3 patients — the difference obse-
rved was statistically significant (p < 0.05).
In the second Holter ECG recording, episodes
of ischemia were observed in 13 patients (20%). In
7 patients there were episodes of ST-segment lo-
wering of 1.0–2.0 mm, in 1 patient > 2.0 mm and in
the remaining 5 patients both 1.0–2.0 mm and
> 2.0 mm. It has been assessed if the episodes of
ischemia observed in Holter ECG recording befo-
re control coronary angiography allow to predict the
occurrence of restenosis. Results of the analysis de-
scribed above are shown in Table 3.
Assessment of heart rate variability
examination for identification of patients
with restenosis
Heart rate variability analysis was also perfor-
med during 24 h Holter ECG monitoring, that was
Table 2. Indexes of diagnostic efficacy of ischemic episodes and ventricular extrasystoles (VES) regis-
tered in Holter ECG monitoring after angioplasty procedure to identify patients with restenosis.
Parameter Sensitivity Specificity PPV NPV OR 95% CI p
ST 1.0–2.0 mm 27 83 36 76 1.776 0.434–7.19 NS
ST > 2.0 mm 7 93 25 73 0.905 0.087–9.44 NS
VES > 50/24 h 53 76 44 82 3.543 1.025–12.224 0.055
VES ≥ 1:1000 20 85 33 74 1.458 0.315–6.759 NS
PPV — positive predictive value, NPV — negative predictive value, OR — odds ratio, CI — confidence interval
Table 3. Indexes of diagnostic efficacy of ischemic episodes and ventricular extrasystoles (VES) regis-
tered in Holter ECG monitoring before control coronary angiography to identify patients with restenosis.
Parameter Sensitivity Specificity PPV NPV OR 95% CI p
ST 1.0–2.0 mm 27 80 33 74 1.455 0.365–5.79 NS
ST > 2.0 mm 7 88 17 71 0.500 0.053–4.674 NS
VES > 50/24 h 47 85 54 81 5.104 1.344–19.379 < 0.05
VES ≥ 1:1000 33 95 63 81 6.17 1.254–30.334 < 0.05
PPV — positive predictive value, NPV — negative predictive value, OR — odds ratio, CI — confidence interval
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performed in all patients after the angioplasty
procedure and after 6 months — before control co-
ronary angiography.
One patient (MS; no. 23) was excluded from that
analysis, because it was impossible to assess his
second Holter ECG recording for technical reasons.
In the evaluation of heart rate variability the
following indexes of sinus rhythm variability were
calculated according to standard procedure: SDNN,
SDNNI, SDANN, rMSSD and pNN50.
Significant differences were observed in initial
recording between the group of patients with reste-
nosis and the group without restenosis, concerning
two of the calculated parameters: rMSSD and pNN50,
that were lower in the group of patients without re-
stenosis compared to patients with restenosis. De-
tailed results of that analysis are shown in Table 4.
In the second recording that was performed
before control coronary angiography no significant
differences between the group of patients with re-
stenosis and patients without restenosis were ob-
served concerning any calculated heart rate varia-
bility parameter. Detailed results of that analysis
are shown in Table 5.
Prognostic value of selected heart rate varia-
bility parameters for the determination of the pro-
bability of restenosis was also assessed. The ana-
lysis included two parameters: rMSSD and pNN50
that were significantly different in patients with
restenosis and patients without restenosis in the
initial recording. Assuming rMSSD value ≥ 30 ms
as the cut-off point it was found that such value al-
lows to determine the probability of the occurren-
ce of restenosis with  sensitivity of 60% and speci-
ficity of 76%. Moreover, the value of pNN50 ≥ 8% in
initial recording allows to predict the occurrence of
restenosis with sensitivity of 60% and specificity
of 78%. Detailed results of that analysis are shown
in Table 6.
Discussion
Assessment of the incidence of restenosis
in Holter ECG monitoring
In the first and second recording there were
no differences between the group of patients with
and without restenosis, as regards mean, minimum
and maximum heart rate.
In the first Holter ECG recording, similarly to
the second recording, episodes of ischemia were
observed in 13 patients. The analysis of Table 2 and 3
shows that their diagnostic efficacy to identify pa-
tients with restenosis was poor (sensitivity of 7–
–27%, specificity of 80–98%).
In the first Holter ECG recording, ventricular
extrasystoles occurred in 39 patients and in 9 pa-
tients their burden was greater than 1:1000. It has
been observed that extrasystoles in number greater
than 50/day occurred more often in the group of
patients that developed restenosis and the differen-
ce observed was statistically significant. Similar
observations also concern the second Holter ECG
Table 4. Results of heart rate variability assess-
ment in patients with restenosis and patients
without restenosis — initial recording after per-
cutaneous transluminal coronary angioplasty.
Restenosis No restenosis P
(n = 15)  (n = 40)
SDNN 119.6±30.3 118.8±30.7 NS
SDANN 106.7±30.7 109.3±30.7 NS
SDNNI 50.1±14.9 44.8±11.9 NS
rMSSD 34.0±14.6 24±8.8 < 0.05
pNN50 9.1±6.8 5.2±5.2 0.61
Table 5. Results of heart rate variability assess-
ment in patients with restenosis and patients
without restenosis — second recording before
control coronary angiography.
Restenosis No restenosis P
(n = 15)  (n = 40)
SDNN 129.1±35.4 121.8±30.5 NS
SDANN 114.2±36.8 107.1±29.8 NS
SDNNI 53.4±18.5 52.9±13.0 NS
rMSSD 31.1±15.8 29.8±9.9 NS
pNN50 9.0±11.3 8.4±7.4 NS
Table 6. Indexes of diagnostic efficacy of selected heart rate variability parameters for the identification
of patients with restenosis.
Parameter Sensitivity Specificity PPV NPV OR 95% CI p
rMSSD ≥ 30 ms (0 mm) 60 76 47 84 4.650 1.325–16.32 < 0.05
pNN50 ≥ 8% (0 mm) 60 78 50 84 5.333 1.497–19.01 < 0.05
PPV — positive predictive value, NPV — negative predictive value, OR — odds ratio, CI — confidence interval
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recording that was performed before control coro-
nary angiography, in which ventricular extrasysto-
les occurred in 37 patients and in 8 patients their
burden was greater than 1:1000. Also in that recor-
ding it has been observed that extrasystoles in num-
ber greater than 50/day occurred more often in the
group of patients that developed restenosis and the
difference observed was statistically significant.
Though the sensitivity of that parameter for iden-
tification of patients with restenosis — as it results
from Table 2 and 3 — is not too large (approxima-
tely 50%), it is still undoubtedly larger than the sen-
sitivity of ST-segment lowering recorded in Holter
ECG registration (it reaches the maximum value of
27%), being similarly specific. Hence the positive
and negative prognostic values of arrhythmia as
a marker of restenosis are definitely larger than tho-
se of the ischemic episodes observed.
Relatively few studies concern the significan-
ce of Holter ECG monitoring in patients after co-
ronary angioplasty procedures. A successful coro-
nary angioplasty procedure causes a decrease in
a number and duration of ischemic episodes that
are recorded in Holter monitoring, which has been
demonstrated in several studies [5–7]. Angiopla-
sty leads to nearly total resolution of symptoma-
tic ischemic episodes, nevertheless episodes of si-
lent ischemia may be still present in some patients;
moreover, they occur also in some patients in
whom they were not observed before the proce-
dure [5, 7]. The occurrence of ischemic episodes
after PTCA may also be the result of incomplete
revascularization [5, 8].
The sensitivity of Holter monitoring to identi-
fy myocardial ischemia reported in literature varies
from 58% to 81% and the specificity from 61% to
95%. It depends however on the probability of co-
ronary artery disease occurrence in the investiga-
ted population [1]. Then why in our study the sen-
sitivity of recorded ischemic episodes to identify
patients with restenosis was so small and it varied
from 7% to 27%? It results primarily from the cha-
racteristics of the study group (patients with one-
vessel disease) and the large number of patients
with asymptomatic restenosis. Some explanation
may also be found in the results published by Camp-
bell et al. [9] who demonstrated that ischemic chan-
ges in Holter recording occur only in those patients
with angina pectoris, in whom they appear at small
workload during exercise test (before the end of 6th
minute of the test according to Bruce’s protocol at
heart rate lower than 150/min) or maintain more
than 5 minutes after the termination of exercise
— in our study group such patients were few.
We made one interesting observation that untill
now has not been reported by other authors, concer-
ning higher sensitivity of ventricular extrasystoles
recorded in ECG monitoring (criterion: > 50/day)
compared to ischemic changes — with similar spe-
cificity of those parameters — for identification
of patients with restenosis. Higher incidence of
ventricular extrasystoles recorded after 6 months
in patients with restenosis may be explained by the
influence of ischemia, but such explanation of the
origin of arrhythmia immediately after the proce-
dure of complete revascularization of the heart se-
ems to be unfounded.
Reference to the results of studies already
published is also difficult, since in available litera-
ture (MEDLINE) that matter has been discussed
by authors of only one study over a small group of
41 patients [10], and they demonstrated, similarly
to our results, that ischemic changes that appear
after the procedure of angioplasty do not allow to
predict the presence of restenosis.
Assessment of the incidence of restenosis
with heart rate variability examination
Heart rate variability analysis was also perfor-
med during 24 h Holter ECG monitoring, that was
performed in all patients after the angioplasty pro-
cedure and after 6 months — before control corona-
ry angiography. In evaluation of heart rate variabili-
ty, the following indexes of sinus rhythm variability
were calculated according to standard procedure:
SDNN, SDNNI, SDANN, rMSSD and pNN50.
In the initial evaluation, higher values of
rMSSD and pNN50 were observed in patients with
restenosis than in patients without restenosis, and
the difference was statistically significant. There
were no differences between those two groups in
other parameters. In the second recording, perfor-
med before control coronarography, no significant
differences of values of any HRV parameter were
observed between the groups of patients with and
without restenosis.
The interpretation of those observations is fa-
irly difficult. The differences of rMSSD and pNN50
observed in the first recording between patients
with and without restenosis may favor the decision
that the patients in whom those parameters have
higher values are more at risk of developing reste-
nosis than other patients. For the two parameters
an attempt was made to determine cut-off values
to differentiate the group of patients with and wi-
thout restenosis. It was established that rMSSD
values ≥ 30 ms as well as pNN50 values ≥ 8% in the
initial recording allow to determine the probability
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of the occurrence of restenosis with a fairly high
sensitivity and specificity. Lack of differences in the
calculated HRV parameters after 6 months after
PTCA suggests that the HRV assessment at that
stage is rather insignificant for the identification of
patients with restenosis.
Few authors assessed the influence of angio-
plasty procedures on changes of heart rate variabi-
lity parameters. Wennerblom et al. [11] observed
a decrease of rMSSD and pNN50 in patients
with angina after a successful PTCA procedure
compared to a healthy, age-matched control group,
while SDNN and SDANN values were not different
in those two groups of patients. After 1 and 6 mon-
ths from the angioplasty procedure those differen-
ces faded away, hence the conclusion that after
a successful angioplasty procedure reduced para-
sympathetic activity normalizes gradually, while the
sympathetic activity (related to the increased mor-
tality after myocardial infarction), represented by
SDNN and SDANN, does not change. Similarly to
Wennerblom, Osterhues et al. [12] observed
a statistically insignificant decrease of rMSSD,
pNN50 and SDNNI, while the values of SDNN and
SDANN had increased.
Research on heart rate variability parameters
in patients with acute myocardial infarction under-
going primary angioplasty [13] or postponed angio-
plasty [14] also indicate biphasic reaction of the
autonomous nervous system, characterized by an
initial decrease and successive increase of vagus
nerve activation with a gradual decrease of sympa-
thetic activation.
Those observations are partially coherent with
ours. In our study group in patients without reste-
nosis an initially reduced parasympathetic activity
was observed (represented by rMSSD and pNN50)
which then gradually normalized in such a way that
after 6 months there was no difference between the
group of patients with and without restenosis.
According to Osterhues et al. [12] it may prove that
the restitution of normal autonomic activity is de-
layed after successful revascularization, however it
remains undetermined why the parasympathetic
activity after angioplasty procedure is reduced in
patients in whom restenosis is not found in the suc-
cessive observation.
It is virtually impossible to relate to studies that
have already been published on the influence of
restenosis after angioplasty on HRV parameters. In
the available literature (MEDLINE) the authors of
only one study of a small group of 25 patients have
focused on that issue [15] and discovered a decre-
ase of SDNN index in patients with restenosis,
while SDANN and rMSSD remained unchanged.
Those observations are different from ours, hence
the conclusion that the actual role of heart rate va-
riability assessment in patients after PTCA needs
some further studies.
Conclusions
1. The role of ST-segment analysis in 24-hour
Holter ECG recording for the evaluation of the
occurrence of restenosis after an angioplasty
procedure of an isolated lesion within corona-
ry arteries seems to be limited.
2. The observed correlation of a more frequent
incidence of restenosis with abundant ventri-
cular arrhythmia in 24-hour Holter ECG mo-
nitoring needs further studies.
3. The assessment of the actual role of heart rate
variability in patients after PTCA procedure
needs further evaluation.
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